Michele Guida

Also affiliated with Istituti di Ricovero e Cura a Carattere Scientifico

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Correlation between efficacy and toxicity in pts with pretreated advanced melanoma treated within the Italian cohort of the ipilimumab expanded access programme (EAP).”.

Correlation between efficacy and toxicity in pts with pretreated advanced melanoma treated within the Italian cohort of the ipilimumab expanded access programme (EAP).

Journal of Clinical Oncology(2013)10.1200/jco.2013.31.15_suppl.9065

N/A

0.416DataRank · unranked

15 citations

Antonio M Grimaldi, Paolo Antonio Ascierto, Paola Queirolo, Michele Del Vecchio, Ruggero Ridolfi +15 more

1074P Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1459

N/A

0.165DataRank · unranked

2 citations

Anna Maria Di Giacomo, Pietro Quaglino, V. Chiarion Sileni, Paola Queirolo, Federica De Galitiis +15 more